Mesenchymal stem cells prevent hypertrophic scar formation via inflammatory regulation when undergoing apoptosis.

PubWeight™: 1.90‹?› | Rank: Top 3%

🔗 View Article (PMID 24714203)

Published in J Invest Dermatol on April 08, 2014

Authors

Shiyu Liu1, Lan Jiang2, Haijian Li2, Haigang Shi3, Hailang Luo4, Yongjie Zhang4, Chunyan Yu5, Yan Jin1

Author Affiliations

1: 1] Research and Development Center for Tissue Engineering, Fourth Military Medical University, Xi'an, Shaanxi, China [2] Department of Oral Histology and Pathology, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi, China.
2: 1] Research and Development Center for Tissue Engineering, Fourth Military Medical University, Xi'an, Shaanxi, China [2] Department of Dermatology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
3: Research and Development Center for Tissue Engineering, Fourth Military Medical University, Xi'an, Shaanxi, China.
4: 1] Research and Development Center for Tissue Engineering, Fourth Military Medical University, Xi'an, Shaanxi, China [2] Xi'an Institute of Tissue Engineering and Regenerative Medicine, Xi'an, Shaanxi, China.
5: Department of Dermatology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.

Articles citing this

Mesenchymal stem cell-mediated suppression of hypertrophic scarring is p53 dependent in a rabbit ear model. Stem Cell Res Ther (2014) 0.89

Insight into Reepithelialization: How Do Mesenchymal Stem Cells Perform? Stem Cells Int (2015) 0.78

Potency of umbilical cord blood- and Wharton's jelly-derived mesenchymal stem cells for scarless wound healing. Sci Rep (2016) 0.78

The Immunomodulatory Effects of Mesenchymal Stem Cells in Prevention or Treatment of Excessive Scars. Stem Cells Int (2015) 0.77

Shikonin reduces TGF-β1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts. Int J Mol Med (2015) 0.77

Studying the complex expression dependences between sets of coexpressed genes. Biomed Res Int (2014) 0.75

Comparison between Stromal Vascular Fraction and Adipose Mesenchymal Stem Cells in Remodeling Hypertrophic Scars. PLoS One (2016) 0.75

Stromal Vascular Fraction Combined with Shock Wave for the Treatment of Peyronie's Disease. Plast Reconstr Surg Glob Open (2016) 0.75

JID VisualDx quiz: October 2014. Scar. J Invest Dermatol (2014) 0.75

Cells to Surgery Quiz: November 2014. J Invest Dermatol (2014) 0.75

Cell Injury-Induced Release of Fibroblast Growth Factor 2: Relevance to Intracerebral Mesenchymal Stromal Cell Transplantations. Stem Cells Dev (2015) 0.75

MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment. Mol Diagn Ther (2017) 0.75

Anti-aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application. Aging Cell (2017) 0.75

Articles cited by this

Apoptosis: a review of programmed cell death. Toxicol Pathol (2007) 17.92

Wound repair and regeneration. Nature (2008) 12.30

Mesenchymal stem cells in health and disease. Nat Rev Immunol (2008) 11.14

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med (2008) 8.79

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell (2009) 7.62

Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med (2011) 6.14

Why are MSCs therapeutic? New data: new insight. J Pathol (2009) 5.25

Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A (2007) 5.17

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science (1997) 4.58

Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med (2000) 3.94

IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol (2008) 3.53

Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats. Gastroenterology (2010) 3.17

Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells (2008) 3.12

Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther (2011) 3.06

Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) (2005) 3.00

Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell (2012) 2.87

Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation (1999) 2.68

Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. Blood (2011) 2.65

Potential cellular and molecular causes of hypertrophic scar formation. Burns (2008) 2.39

Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol (2012) 2.36

Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci (2004) 2.27

TSG-6: a pluripotent inflammatory mediator? Biochem Soc Trans (2006) 2.20

Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell (2010) 2.10

Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-α stimulated gene/protein 6. Stem Cells (2011) 1.96

Apoptosis, stem cells, and tissue regeneration. Sci Signal (2010) 1.95

How mesenchymal stem cells interact with tissue immune responses. Trends Immunol (2012) 1.92

Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med (2011) 1.72

Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol (2009) 1.72

Differential injury responses in oral mucosal and cutaneous wounds. J Dent Res (2003) 1.58

Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol Blood Marrow Transplant (2010) 1.56

Scarless fetal wound healing: a basic science review. Plast Reconstr Surg (2010) 1.56

Effects of cyclic compressive loading on chondrogenesis of rabbit bone-marrow derived mesenchymal stem cells. Stem Cells (2004) 1.51

TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds. J Invest Dermatol (2013) 1.47

IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. J Invest Dermatol (2008) 1.43

Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs (2000) 1.42

Hypertrophic scar formation following burns and trauma: new approaches to treatment. PLoS Med (2007) 1.42

The link module from human TSG-6 inhibits neutrophil migration in a hyaluronan- and inter-alpha -inhibitor-independent manner. J Biol Chem (2002) 1.39

Risk factors in the development of stem cell therapy. J Transl Med (2011) 1.38

TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury. J Leukoc Biol (1998) 1.24

Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood (1994) 1.20

Hypertrophic scar model in the rabbit ear: a reproducible model for studying scar tissue behavior with new observations on silicone gel sheeting for scar reduction. Wound Repair Regen (2007) 1.20

Diminished induction of skin fibrosis in mice with MCP-1 deficiency. J Invest Dermatol (2006) 1.18

Synergistic angiogenesis promoting effects of extracellular matrix scaffolds and adipose-derived stem cells during wound repair. Tissue Eng Part A (2010) 1.07

Dermal matrix as a carrier for in vivo delivery of human adipose-derived stem cells. Biomaterials (2008) 1.06

Characterization of mesenchymal stem cells from human normal and hyperplastic gingiva. J Cell Physiol (2011) 1.05

Pre-treatment with IL-1β enhances the efficacy of MSC transplantation in DSS-induced colitis. Cell Mol Immunol (2012) 1.01

Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice. PLoS One (2012) 1.00

Cellular and Molecular Characteristics of Scarless versus Fibrotic Wound Healing. Dermatol Res Pract (2010) 0.97

Transplantation of human mesenchymal stem cells in a non-autogenous setting for bone regeneration in a rabbit critical-size defect model. Acta Biomater (2009) 0.96

Expansion and preservation of multipotentiality of rabbit bone-marrow derived mesenchymal stem cells in dextran-based microcarrier spin culture. J Mater Sci Mater Med (2011) 0.94

Ski, a modulator of wound healing and scar formation in the rat skin and rabbit ear. J Pathol (2011) 0.89

Micronized acellular dermal matrix as an efficient expansion substrate and delivery vehicle of adipose-derived stem cells for vocal fold regeneration. Laryngoscope (2012) 0.87

Genetic engineering and stem cells: combinatorial approaches for cardiac cell therapy. IEEE Eng Med Biol Mag (2008) 0.78